Top
ERCC2 19:45354740:T (W552*) × BLCA ×
Driver potential information
Model BoostDM class BoostDM score
(BLCA) Bladder Urothelial Carcinoma Passenger 0.25
Feature importance

Place the mouse pointer over a mutational feature for additional information. See the FAQs for more details about the feature importance.

Feature Feature value SHAP value
Linear Clustering Score (LCS) 0.00 -0.37 Medium negative
3D Clustering in Cancer Type (3CT) 0.00 -0.21 Medium negative
Recurrent in PFAM Domain (DOM) 0.00 -0.24 Medium negative
PhyloP 100-way Score (PHYLOP) 7.42 1.02 High positive
Stop Codon in Last Exon (NMD) 0.00 0.00 Non-significant
Post-translational Modification Site: Acetylation (ACETYLATION) 0.00 0.00 Non-significant
Post-translational Modification Site: Methylation (METHYLATION) 0.00 0.00 Non-significant
Post-translational Modification Site: Phosphorylation (PHOS) 0.00 0.00 Non-significant
Post-translational Modification Site: Regulatory site (REG) 0.00 0.00 Non-significant
Post-translational Modification Site: Ubiquitination (UB) 0.00 0.00 Non-significant
Consequence Type: Missense (MISSENSE) 0.00 -0.64 Medium negative
Consequence Type: Nonsense (NONSENSE) 1.00 -0.01 Non-significant
Consequence Type: Splice-affecting (SPLICE) 0.00 -0.02 Non-significant